tiprankstipranks
Trending News
More News >
NOVARESE,Inc. (JP:9160)
:9160
Japanese Market
Advertisement

NOVARESE,Inc. (9160) Price & Analysis

Compare
0 Followers

9160 Stock Chart & Stats

¥335.00
¥3.00(0.99%)
At close: 4:00 PM EST
¥335.00
¥3.00(0.99%)

9160 FAQ

What was NOVARESE,Inc.’s price range in the past 12 months?
NOVARESE,Inc. lowest stock price was ¥272.00 and its highest was ¥369.00 in the past 12 months.
    What is NOVARESE,Inc.’s market cap?
    NOVARESE,Inc.’s market cap is ¥8.40B.
      When is NOVARESE,Inc.’s upcoming earnings report date?
      NOVARESE,Inc.’s upcoming earnings report date is Nov 13, 2025 which is in 21 days.
        How were NOVARESE,Inc.’s earnings last quarter?
        NOVARESE,Inc. released its earnings results on Aug 14, 2025. The company reported ¥13.49 earnings per share for the quarter, beating the consensus estimate of N/A by ¥13.49.
          Is NOVARESE,Inc. overvalued?
          According to Wall Street analysts NOVARESE,Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does NOVARESE,Inc. pay dividends?
            NOVARESE,Inc. does not currently pay dividends.
            What is NOVARESE,Inc.’s EPS estimate?
            NOVARESE,Inc.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does NOVARESE,Inc. have?
            NOVARESE,Inc. has 25,073,093 shares outstanding.
              What happened to NOVARESE,Inc.’s price movement after its last earnings report?
              NOVARESE,Inc. reported an EPS of ¥13.49 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.946%.
                Which hedge fund is a major shareholder of NOVARESE,Inc.?
                Currently, no hedge funds are holding shares in JP:9160

                Company Description

                NOVARESE,Inc.

                NOVARESE, Inc. (9160) is a dynamic company operating in the biotechnology sector, specializing in the development and commercialization of innovative healthcare solutions. The company focuses on creating advanced therapeutics and diagnostic tools aimed at addressing unmet medical needs in various therapeutic areas, including oncology and rare diseases. NOVARESE leverages cutting-edge research and technology to enhance patient outcomes and improve overall health management.

                NOVARESE,Inc. (9160) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                ESCRIT Inc.
                IKK Holdings Co., Ltd
                Brass Corp.
                TEAR Corp.
                Take and Give. Needs Co., Ltd.
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis